Group 1: Pinterest - Pinterest's stock price has significantly declined due to third-quarter earnings that fell short of market expectations, despite a 17% year-over-year revenue growth to approximately $1 billion and earnings per share of $0.13, up from $0.04 a year ago [3][4] - The company is facing tariff-related disruptions affecting ad demand from retail giants, but it has shown positive signs such as a 5% year-over-year increase in average revenue per user (ARPU) to $1.78 and a 30% year-over-year increase in free cash flow to $318.4 million [5][6] - Pinterest's user base continues to grow, reaching 600 million monthly active users (MAUs), a 12% year-over-year increase, and the company is enhancing its platform through AI initiatives, which could improve ad revenue [5][6][8] Group 2: Zoetis - Zoetis has faced challenges this year due to declining sales of its new products Librela and Solensia, which treat osteoarthritis pain in pets, but its key product Apoquel continues to perform well and contributes to dermatology revenue growth [9][10] - The company estimates that over 20 million dogs remain untreated or under-treated, indicating significant market potential for its dermatology franchise, which has only reached 12 million dogs since entering the market [11] - Zoetis has a strong history of innovation with 17 products generating over $100 million in annual revenue and over 300 product lines, and it has increased its dividend payouts by 426.3% over the past decade, making it attractive for long-term investors [14][15]
2 Stocks to Buy Near Their 52-Week Lows